These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5423366)

  • 1. Lysostaphin-induced, osmotically fragile Staphylococcus aureus cells.
    Huber TW; Schuhardt VT
    J Bacteriol; 1970 Jul; 103(1):116-9. PubMed ID: 5423366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmotic fragility and viability of lysostaphin-induced staphylococcal spheroplasts.
    Schuhardt VT; Klesius PH
    J Bacteriol; 1968 Sep; 96(3):734-7. PubMed ID: 5732506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electron microscopy and viability of lysostaphin-induced staphylococcal spheroplasts, protoplast-like bodies, and protoplasts.
    Schuhardt VT; Huber TW; Pope LM
    J Bacteriol; 1969 Jan; 97(1):396-401. PubMed ID: 5764340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcal spheroplasts and L-colonies. 3. Induction by lysostaphin.
    Watanakunakorn C; Goldberg LM; Carleton J; Hamburger M
    J Infect Dis; 1969 Jan; 119(1):67-74. PubMed ID: 5765044
    [No Abstract]   [Full Text] [Related]  

  • 5. Light and scanning-beam electron microscopy of wall-defective Staphylococcus aureus induced by lysostaphin.
    Watanakunakorn C; Fass RJ; Klainer AS; Hamburger M
    Infect Immun; 1971 Jul; 4(1):73-8. PubMed ID: 4949481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection of lysostaphin-treated cells of Staphylococcus aureus.
    Riggs HG; Rosenblum ED
    J Virol; 1969 Jan; 3(1):33-7. PubMed ID: 4239098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lysostaphin and its two active components on stable wall-defective forms of Staphylococcus aureus.
    Watanakunakorn C; Browder HP
    J Infect Dis; 1970 Feb; 121(2):124-8. PubMed ID: 5197995
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of the composition of reversion medium on change of Staphylococcus aureus lysostaphin protoplasts to coccal forms and L-forms.
    Kato Y; Hirachi Y; Toda Y; Takemasa N; Kotani S
    Biken J; 1986 Jun; 29(2):39-44. PubMed ID: 3814073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin.
    Francius G; Domenech O; Mingeot-Leclercq MP; Dufrêne YF
    J Bacteriol; 2008 Dec; 190(24):7904-9. PubMed ID: 18835985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid identification of Staphylococcus aureus by using lysostaphin sensitivity.
    Severance PJ; Kauffman CA; Sheagren JN
    J Clin Microbiol; 1980 Jun; 11(6):724-7. PubMed ID: 7430338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of L-phase variant from protoplast of Staphylococcus aureus.
    Makino T
    Microbiol Immunol; 1983; 27(9):749-55. PubMed ID: 6645987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-wall proteins of Staphylococcus aureus : a kinetic study of release by lysostaphin.
    Poutrel B; Dubray G
    Ann Rech Vet; 1978; 9(3):401-7. PubMed ID: 749643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the composition of the reversion medium on the transformation of coccal forms and L-form of Staphylococcus aureus lysostaphin protoplasts].
    Kato Y; Hirachi Y; Toda Y; Kurono M; Takemasa N; Kotani S
    Osaka Daigaku Shigaku Zasshi; 1985 Dec; 30(2):296-303. PubMed ID: 3869230
    [No Abstract]   [Full Text] [Related]  

  • 14. Lytic action of lysostaphin on susceptible and resistant strains of Staphylococcus aureus.
    Zygmunt WA; Browder HP; Tavormina PA
    Can J Microbiol; 1967 Jul; 13(7):845-53. PubMed ID: 6036889
    [No Abstract]   [Full Text] [Related]  

  • 15. Staphylococcus aureus response to lysostaphin in some fermented foods.
    Metcalf RH; Deibel RH
    Appl Microbiol; 1969 Jan; 17(1):63-7. PubMed ID: 5774763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of Polycations on Antibacterial Activity of Lysostaphin].
    Kulikov SN; Khairullin RZ; Varlamov VP
    Prikl Biokhim Mikrobiol; 2015; 51(6):610-5. PubMed ID: 26859963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of staphylococci in clinical and food microbiology laboratories.
    Sperber WH
    CRC Crit Rev Clin Lab Sci; 1976; 7(2):121-84. PubMed ID: 797525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphology and ultrastructure of staphylococcal L colonies: light, scanning, and transmission electron microscopy.
    Fass RJ
    J Bacteriol; 1973 Feb; 113(2):1049-53. PubMed ID: 4570589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of coagulase-negative staphylococci to lysostaphin and other antibiotics.
    Zygmunt WA; Browder HP; Tavormina PA
    Appl Microbiol; 1968 Aug; 16(8):1168-73. PubMed ID: 5675508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology and pathogenicity of microbial spheroplasts and l-forms.
    Feingold DS
    N Engl J Med; 1969 Nov; 281(21):1159-70. PubMed ID: 4899869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.